SCHEDULE 13G/AAccepted Aug 3, 8:31 AM ET
BridgeBio Pharma, Inc. SCHEDULE 13G/A
Accepted (ET)
8:31 AM
Aug 3, 2026
Filed
Aug 3, 2026
Documents
2
Size
47.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.